Effects of coenzyme Q10 on salivary secretion

Clinical Biochemistry

Volumn 44, Issue 8-9, 2011, Pages 669-674

  Ryo, Koufuchi ^a   Ito, Atsuko ^a   Takatori, Rie ^a   Tai, Yoshinori ^a   Arikawa, Kazumune ^b   Seido, Taro ^a   Yamada, Takashi ^a   Shinpo, Keiko ^a   Tamaki, Yoh ^c   Fujii, Kenji ^d   Yamamoto, Yorihiro ^e   Saito, Ichiro ^a  

^a TSURUMI UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^d KANEKA CORPORATION   (Japan)

^e TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

Antioxidant; CoQ10; Dry mouth; Saliva; Sj gren's syndrome

Indexed keywords

PLACEBO; UBIDECARENONE; UBIQUINONE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TRANSPORT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVATION; XEROSTOMIA;

ADMINISTRATION, ORAL; AGED; ANTIOXIDANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; SALIVATION; UBIQUINONE;

EID: 79955834477     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.03.029     Document Type: Article

References (33)

1. Chambers M.S., Garden A.S., Kies M.S., Martin J.W. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 2004, 26:796-807.
2. Flink H. Studies on the prevalence of reduced salivary flow rate in relation to general health and dental caries, and effect of iron supplementation. Swed. Dent. J. Suppl. 2007, 52:3-50.
3. Helbock H.J., Beckman K.B., Shigenaga M.K., et al. DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc. Natl Acad. Sci. U.S.A. 1998, 95:288-293.
4. Ryo K., Yamada H., Nakagawa Y., et al. Possible involvement of oxidative stress in salivary gland of patients with Sjogren's syndrome. Pathobiology 2006, 73:252-260.
5. Ishikawa Y., Eguchi T., Skowronski M.T., Ishida H. Acetylcholine acts on M3 muscarinic receptors and induces the translocation of aquaporin5 water channel via cytosolic Ca2+ elevation in rat parotid glands. Biochem. Biophys. Res. Commun. 1998, 245:835-840.
6. Kalen A., Appelkvist E.L., Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids 1989, 24:579-584.
7. Stocker R., Bowry V.W., Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc. Natl Acad. Sci. U.S.A. 1991, 88:1646-1650.
8. Bowry V.W., Stanley K.K., Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl Acad. Sci. U.S.A. 1992, 89:10316-10320.
9. Redfearn E.R., Pumphrey A.M. Oxidation-reduction levels of ubiquinone (coenzyme Q) in different metabolic states of rat liver mitochondria. Biochem. Biophys. Res. Commun. 1960, 3:650-653.
10. Folkers K., Vadhanavikit S., Mortensen S.A. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc. Natl Acad. Sci. U.S.A. 1985, 82:901-904.
11. Izumi Y., Watanabe C., Oomoto K., Nakamura S. Clinical effect of coenzymeQ10 on chronic progressive external ophthalmoplegia associated with impaired glucose tolerance and macrocytic normochromic anemia. Shinkeichiryo 1997, 14:569-573.
12. Shults C.W., Oakes D., Kieburtz K., Beal M.F., Haas R., Plumb S., Juncos J.L., Nutt J., Shoulson I., Carter J., Kompoliti K., Perlmutter J.S., Reich S., Stern M., Watts R.L., Molho E., Harrison M., Lew M. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch. Neurol. 2002, 59:1541-1550. Parkinson Study Group.
13. Huntington Study Group A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease. Neurology 2001, 57:397-404.
14. Fox R.I., Saito I. Criteria for diagnosis of Sjögren's syndrome. Rheum. Dis. Clin. North Am. 1994, 20:391-407.
15. Kohler P.F., Winter M.E. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum. 1985, 28:1128-1132.
16. Folkers K., Littarru G.P., Ho L., Runge T.M., Havanonda S., Cooley D. Evidence for a deficiency of coenzyme Q10 in human heart disease. Int. Z. Vitaminforsch. 1970, 40:380-390.
17. Jameson S. Statistical data support prediction of death within 6months on low levels of coenzyme Q10 and other entities. Clin. Investig. 1993, 71:S137-9.
18. Langsjoen P.H., Langsjoen A.M. Supplemental ubiquinol in patients with advanced congestive heart failure. Biofactors 2008, 32:119-128.
19. Yan J., Fujii K., Yao J., Kishida H., Hosoe K., Sawashita J., Takeda T., Mori M., Higuchi K. Reduced coenzyme Q10 supplementation decelerates senescence in SAMP1 mice. Exp. Gerontol. 2006, 41:130-140.
20. McRee J.T., Hanioka T., Shizukuishi S., Folkers K. Therapy with coenzyme Q10 for patients with periodontal disease. J. Dent. Health. 1993, 43:659-666.
21. Hanioka T., Tanaka M., Ojima M., Shizukuishi S., Folkers K. Effect of topical application of coenzyme Q10 on adult periodontitis. Mol. Aspects Med. 1994, 15:s241-248.
22. Takeda I., Kizu Y., Yoshitaka O., Saito I., Yamane G.Y. Possible role of nitric oxide in radiation-induced salivary gland dysfunction. Radiat. Res. 2003, 159:465-470.
23. Ishikawa Y., Cho G., Yuan Z., Skowronski M.T., Pan Y., Ishida H. Water channels and zymogen granules in salivary glands. J. Pharmacol. Sci. 2006, 100:495-512.
24. Takahashi T., Sugimoto N., Takahata K., Okamoto T., Kishi T. Cellular antioxidant defense by a ubiquinol-regenerating system coupled with cytosolic NADPH-dependent ubiquinone reductase: protective effect against carbon tetrachloride-induced hepatotoxicity in the rat. Biol. Pharm. Bull. 1996, 19:1005-1012.
25. Aberg F., Appelkvist E.L., Dallner G., Ernster L. Distribution and redox state of ubiquinones in rat and human tissues. Arch. Biochem. Biophys. 1992, 295:230-234.
26. Mohr D., Umeda Y., Redgrave T.G., Stocker R. Antioxidant defenses in rat intestine and mesenteric lymph. Redox Rep. 1999, 4:79-87.
27. Wada H., Goto H., Hagiwara S., Yamamoto Y. Redox status of coenzyme Q10 is associated with chronological age. J. Am. Geriatr. Soc. 2007, 55:1141-1142.
28. Shih P.H., Yen G.C. Differential expressions of antioxidant status in aging rats: the role of transcriptional factor Nrf2 and MAPK signaling pathway. Biogerontology 2007, 8:71-80.
29. Parihar M.S., Kunz E.A., Brewer G.J. Age-related decreases in NAD(P)H and glutathione cause redox declines before ATP loss during glutamate treatment of hippocampal neurons. J. Neurosci. Res. 2008, 86:2339-2352.
30. Kishi T., Kishi H., Watanabe T., Folkers K. Bioenergetics in clinical medicine. XI. Studies on coenzyme Q and diabetes mellitus. J. Med. 1976, 7:307-321.
31. Mizuno K., Tanaka M., Nozaki S., et al. Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition 2008, 24:293-299.
32. Lim S.C., Tan H.H., Goh S.K., et al. Oxidative burden in prediabetic and diabetic individuals: evidence from plasma coenzyme Q(10). Diabet. Med. 2006, 23:1344-1349.
33. Lonnrot K., Holm P., Lagerstedt A., Huhtala H., Alho H. The effects of lifelong ubiquinone Q10 supplementation on the Q9 and Q10 tissue concentrations and life span of male rats and mice. Biochem. Mol. Biol. Int. 1998, 44:727-737.